Zur Rose Group Revenue and Competitors

As Europe’s largest e-commerce pharmacy and one of the leading medical wholesalers in Switzerland, listed in Swiss Stock Exchange, the Zur Rose Group delivers healthcare products to more than 12 million consumers across Europe. With its strong international presence, the Zur Rose Group consists of some of Europe’s best-known brands – including Germany’s DocMorris, Medpex, and Spain’s Promofarma, France’s Doctipharma. The Group employs more than 2,200 people at sites in Switzerland, Germany, the Netherlands, Spain and France, and generated CHF 2,034 million external revenue in 2021 financial year. Zur Rose is actively driving ahead its positioning as a comprehensive provider of healthcare products and services aligned with the Group’s vision to become THE Healthcare Ecosystem of Europe bringing the best products and solutions enabled by data and digital to its customers along their health journeys – its recent acquisition of TeleClinic, Germany’s largest telemedicine provider, demonstrates its ambition in this space. Building on its treatment delivery services, digital solutions, technology, data and analytics, the Zur Rose Group is working to ensure better quality of life and better healthcare outcomes for everyone, anytime, anywhere; enabling access to health in one click.